Jan Berger, a member of the CHVI board of directors, is co-author of the study Prevalence of Antihypertensive, Antidiabetic, and Dyslipidemic Prescription Medication Use Among Children and Adolescents published in the April edition of Archives of Pediatric and Adolescent Medicine. Dr. Berger, with Joshua N. Lieberman and Meredith Lewis, studied trends in prescribing blood pressure, diabetes and cholesterol drugs to children and teenagers.
Tags: Berger, Jan, strategic advisor, teen
Follow CHVI on Facebook